Lazard Capital Starts Vanda Pharmaceuticals (VNDA) at Buy

February 5, 2013 6:35 AM EST
Get Alerts VNDA Hot Sheet
Price: $13.25 -2.57%

Rating Summary:
    8 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade VNDA Now!
Join SI Premium – FREE
Lazard Capital initiates coverage on Vanda Pharmaceuticals (NASDAQ: VNDA) with a Buy. PT $11.00.

For an analyst ratings summary and ratings history on Vanda Pharmaceuticals click here. For more ratings news on Vanda Pharmaceuticals click here.

Shares of Vanda Pharmaceuticals closed at $3.91 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Hot New Coverage, New Coverage

Related Entities


Add Your Comment